skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Subacute toxicity study in Wistar rats fed with StemEnhanceTM, an extract from Aphanizomenon flos-aquae

Original Research

(1055) Views  (272) Full article downloads

Authors: Levent Dirikolu, Thushara Chakkath, Susan Ball-Kell, et al

Published Date December 2010 Volume 2010:2 Pages 125 - 135
DOI: http://dx.doi.org/10.2147/NDS.S15533

Levent Dirikolu1, Thushara Chakkath1, Susan Ball-Kell2, Christy Elamma2, Timothy M Fan3, David J Schaeffer1
1Department of Comparative Biosciences, 2Veterinary Diagnostic Laboratory, 3Comparative Oncology Research Laboratory, Department of Veterinary Clinical Medicine, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, Urbana, IL, USA

Abstract: This study evaluated the safety (absence of toxicity) of StemEnhance™, an extract of the blue-green alga Aphanizomenon flos-aquae that is used as a health supplement. Groups of 12 rats of each sex were given either 5% glycerin in water (control) or 600 mg/kg of StemEnhance prepared in 5% glycerin in water for 2 weeks by oral gavage followed by 2 weeks of observation. The administration of StemEnhance had no effect on behavior, food and water intake, growth, or survival. Values at the end of dosing and observation periods did not reveal differences between treated and control groups for hematology and clinical chemistry. There were no significant differences in the gross and histopathology of the reproductive organs in either males or females. Sperm motility parameters were similar for control and treated males. Our results show that StemEnhance at doses ~20 times the maximum label-recommended daily dose did not produce adverse effects in Wistar rats after subacute treatment.

Keywords: algal toxicology, blue-green algae, cyanobacteria, Aphanizomenon flos-aquae




 

Other articles by Dr Dirikolu



Readers of this article also read:

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Dietary habits and cardiovascular disease risk in middle-aged and elderly populations: a review of evidence
Berberine: metabolic and cardiovascular effects in preclinical and clinical trials
Use and potential of nanotechnology in cosmetic dermatology
Preferences for heat, cold, or contrast in patients with knee osteoarthritis affect treatment response
Advantages of dietary, exercise-related, and therapeutic interventions to prevent and treat sarcopenia in adult patients: an update
Facial rejuvenation for middle-aged women: a combined approach with minimally invasive procedures
Efficacy of a novel, biologically active food supplement in type 2 diabetes mellitus: a patient-blinded, prospective, clinical trial
Minimally invasive treatment of lumbar spinal stenosis with a novel interspinous spacer
A comparison of the efficacy, safety, and longevity of two different hyaluronic acid dermal fillers in the treatment of severe nasolabial folds: a multicenter, prospective, randomized, controlled, single-blind, within-subject study
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University